Free Trial
Luke Sergott

Luke Sergott Analyst Performance

Director at Barclays

Luke Sergott is a stock analyst at Barclays, covering 25 publicly traded companies across a range of sectors. Over the past year, Luke Sergott has issued 55 stock ratings, including buy, hold, and sell recommendations. While full access to Luke Sergott's proprietary MarketBeat Analyst Rating is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Luke Sergott's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ratings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
57 Last 5 Years
Buy Recommendations
56.14% 32 Buy Ratings
Companies Covered
25 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy56.1%32 ratings
Hold38.6%22 ratings
Sell5.3%3 ratings

Out of 57 total stock ratings issued by Luke Sergott at Barclays, the majority (56.1%) have been Buy recommendations, followed by 38.6% Hold and 5.3% Sell.

Exchange Coverage

ExchangePercentageCount
NASDAQ
60.0% of companies on NASDAQ
15 companies
NYSE
40.0% of companies on NYSE
10 companies

Luke Sergott, an analyst at Barclays, currently covers 25 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
24 companies
96.0%
Computer and Technology
1 company
4.0%

Luke Sergott of Barclays specializes in stock coverage within the Medical sector, with additional focus on Computer and Technology companies.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
9 companies
36.0%
MEDICAL SERVICES
7 companies
28.0%
MED INSTRUMENTS
5 companies
20.0%
MED PRODUCTS
1 company
4.0%
MEDICAL INFO SYS
1 company
4.0%
INSTRU - SCIENTFC
1 company
4.0%
MED/DENTAL - SUPP
1 company
4.0%

About Luke Sergott

Experienced healthcare analyst with a focus in public and private Life Sciences and Diagnostics companies.
Follow on LinkedIn

Luke Sergott's Ratings History at Barclays

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
8/29/2025Reiterated Rating$124.70$125.00Equal Weight
Natera, Inc. stock logo
NTRA
Natera
8/8/2025Reiterated Rating$141.08$210.00Overweight
10x Genomics stock logo
TXG
10x Genomics
8/8/2025Reiterated Rating$12.80$15.00Overweight
Fortrea Holdings Inc. stock logo
FTRE
Fortrea
8/7/2025Reiterated Rating$6.58$6.00Underweight
Exact Sciences Corporation stock logo
EXAS
Exact Sciences
8/7/2025Lower Price Target$46.91$55.00Overweight
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
8/7/2025Boost Price Target$150.60$165.00Equal Weight
Avantor, Inc. stock logo
AVTR
Avantor
8/4/2025Reiterated Rating$11.46$13.00Overweight
Bruker Corporation stock logo
BRKR
Bruker
8/4/2025Lower Price Target$34.72$43.00Overweight
Incyte Corporation stock logo
INCY
Incyte
8/1/2025Initiated Coverage$74.89$90.00Overweight
Illumina, Inc. stock logo
ILMN
Illumina
8/1/2025Boost Price Target$97.65$90.00Underweight
Icon Plc stock logo
ICLR
Icon
7/25/2025Boost Price Target$186.16$180.00Equal Weight
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
7/24/2025Boost Price Target$466.84$490.00Equal Weight
Medpace Holdings, Inc. stock logo
MEDP
Medpace
7/23/2025Boost Price Target$477.73$450.00Equal Weight
IQVIA Holdings Inc. stock logo
IQV
IQVIA
7/23/2025Boost Price Target$187.89$185.00Equal Weight
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
6/25/2025Lower Price Target$1.18$1.50Equal Weight
Medpace Holdings, Inc. stock logo
MEDP
Medpace
6/24/2025Initiated Coverage$308.64$300.00Equal Weight
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
6/24/2025Initiated Coverage$1,164.53$1,325.00Overweight
Qiagen N.V. stock logo
QGEN
Qiagen
6/24/2025Initiated Coverage$46.72$55.00Overweight
Repligen Corporation stock logo
RGEN
Repligen
6/24/2025Initiated Coverage$120.11$150.00Overweight
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
6/24/2025Initiated Coverage$217.05$245.00Equal Weight
10x Genomics stock logo
TXG
10x Genomics
6/24/2025Reiterated Rating$10.94$13.00Overweight
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
6/24/2025Lower Price Target$401.19$450.00Equal Weight
Sotera Health Company stock logo
SHC
Sotera Health
6/24/2025Lower Price Target$11.20$13.00Overweight
Certara, Inc. stock logo
CERT
Certara
5/8/2025Upgrade$11.46$14.00Overweight
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
5/8/2025Boost Price Target$141.77$155.00Equal Weight
Bruker Corporation stock logo
BRKR
Bruker
5/8/2025Lower Price Target$42.13$46.00Overweight
Avantor, Inc. stock logo
AVTR
Avantor
4/28/2025Lower Price Target$12.93$15.00Overweight
Sotera Health Company stock logo
SHC
Sotera Health
4/10/2025Lower Price Target$10.61$12.00Overweight
IQVIA Holdings Inc. stock logo
IQV
IQVIA
4/10/2025Reiterated Rating$157.02$170.00Equal Weight
Icon Plc stock logo
ICLR
Icon
4/10/2025Reiterated Rating$155.49$165.00Equal Weight
Fortrea Holdings Inc. stock logo
FTRE
Fortrea
4/10/2025Reiterated Rating$6.45$6.00Underweight
Danaher Corporation stock logo
DHR
Danaher
4/10/2025Upgrade$192.18$205.00Overweight
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
4/10/2025Lower Price Target$128.77$145.00Equal Weight
Certara, Inc. stock logo
CERT
Certara
4/10/2025Lower Price Target$9.02$11.00Equal Weight
Avantor, Inc. stock logo
AVTR
Avantor
4/10/2025Lower Price Target$14.97$18.00Overweight
10x Genomics stock logo
TXG
10x Genomics
4/10/2025Lower Price Target$7.81$12.00Overweight
Twist Bioscience Corporation stock logo
TWST
Twist Bioscience
4/10/2025Lower Price Target$35.90$45.00Overweight
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
4/10/2025Lower Price Target$424.64$475.00Equal Weight
Fortrea Holdings Inc. stock logo
FTRE
Fortrea
3/4/2025Lower Price Target$10.38$12.00Equal Weight
Certara, Inc. stock logo
CERT
Certara
2/28/2025Boost Price Target$11.87$13.00Equal Weight
Sotera Health Company stock logo
SHC
Sotera Health
2/28/2025Lower Price Target$12.47$16.00Overweight
Icon Plc stock logo
ICLR
Icon
2/21/2025Lower Price Target$201.84$240.00Overweight
Sotera Health Company stock logo
SHC
Sotera Health
2/18/2025Lower Price Target$13.48$17.00Overweight
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
2/18/2025Lower Price Target$152.07$166.00Equal Weight
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
2/10/2025Upgrade$145.21$145.00Equal Weight
Waters Corporation stock logo
WAT
Waters
2/10/2025Upgrade$408.96$415.00Equal Weight
Avantor, Inc. stock logo
AVTR
Avantor
2/10/2025Lower Price Target$19.15$23.00Overweight
10x Genomics stock logo
TXG
10x Genomics
2/10/2025Lower Price Target$14.25$18.00Overweight
Twist Bioscience Corporation stock logo
TWST
Twist Bioscience
2/3/2025Set Price Target$41.31$58.00Overweight
Avantor, Inc. stock logo
AVTR
Avantor
2/3/2025Boost Price Target$22.15$26.00Overweight
IQVIA Holdings Inc. stock logo
IQV
IQVIA
2/3/2025Lower Price Target$200.31$235.00Overweight
Danaher Corporation stock logo
DHR
Danaher
1/30/2025Lower Price Target$223.12$240.00Equal Weight
Exact Sciences Corporation stock logo
EXAS
Exact Sciences
1/23/2025Initiated Coverage$54.79$70.00Overweight
Guardant Health, Inc. stock logo
GH
Guardant Health
1/23/2025Initiated Coverage$47.20$60.00Overweight
Natera, Inc. stock logo
NTRA
Natera
1/23/2025Initiated Coverage$171.93$200.00Overweight